Deterioration of COVID-19 vaccine efficacy by antipsychotic medications in schizophrenia patients

  • 0Junwakai Yahagigawa Hospital, Anjo, Aichi, Japan.

|

|

Summary

This summary is machine-generated.

Antipsychotic medication, particularly risperidone, may reduce COVID-19 vaccine effectiveness in schizophrenia patients. Aripiprazole showed a protective effect, while risperidone increased incidence, highlighting drug-specific impacts on vaccine efficacy.

Area Of Science

  • Immunology
  • Pharmacology
  • Psychiatry

Background

  • Antipsychotic medications can impact vaccine efficacy.
  • Schizophrenia patients show higher COVID-19 incidence post-vaccination compared to controls.
  • Initial observations suggested reduced vaccine protection in schizophrenia inpatients.

Purpose Of The Study

  • To examine the effect of antipsychotic medication on COVID-19 incidence in schizophrenia patients.
  • To compare COVID-19 incidence and vaccine side effects between schizophrenia patients and control hospital staff.
  • To investigate potential drug-specific influences on vaccine effectiveness.

Main Methods

  • A cohort study involving 98 schizophrenia inpatients and 78 control hospital staff.
  • All participants received COVID-19 vaccination between July and September 2021.
  • Comparison of COVID-19 incidence and vaccine-related side effects between the groups.

Main Results

  • Schizophrenia patients had significantly higher COVID-19 incidence (40.8%) versus controls (12.8%).
  • Risperidone monotherapy was linked to increased COVID-19 incidence (65.6%).
  • Aripiprazole use was associated with a significant reduction in incidence (0%).

Conclusions

  • Risperidone may impair immune responses and reduce COVID-19 vaccine effectiveness.
  • Aripiprazole use may offer a protective effect against COVID-19 post-vaccination.
  • Further research is needed to clarify drug-specific anti-vaccine effects and immunological mechanisms.

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview 01:28

159

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...

Psychosis: Goals of Pharmacotherapy 01:26

98

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Drug Therapy 01:28

32

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Antipsychotic Drugs: Therapeutic Uses and Side Effects 01:21

105

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders 01:27

302

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...

Antipsychotic Drugs: Typical and Atypical Agents 01:21

131

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...